You are currently viewing a new version of our website. To view the old version click .

Nanotechnology Applied in Treatment of Important and Global Parasitic Diseases

This special issue belongs to the section “Nanomedicine and Nanotechnology“.

Special Issue Information

Dear Colleagues,

Parasitic diseases represent a serious and complex group of diseases leading to serious clinical manifestations usually associated with poverty. These diseases represent enormous health and economic losses in developing countries and particularly in poor countries of all continents. The etiological treatment of these diseases remains neglected and the drugs available for human treatment have limited efficacy and availability, side effects, and a low percentage of cure, particularly in later infectious. Thus, the need for new compounds in formulations employing special technology for overtaking these challenges is urgent. In the last decades, nanotechnology had brought important advantages for this issue. Thus, Articles or Reviews covering this theme arouse great interest in the scientific community, especially nowadays when the studies of chemotherapy and clinical essays have grown and new compounds proved to be active in pre-clinical studies.

In this Special Issue, original research articles and reviews are welcome.

Prof. Dr. Marta De Lana
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • malaria/Chagas disease/leishmaniasis/schistosomiasis
  • Trypanosoma cruzi
  • chemotherapy
  • nanotechnology
  • new compounds

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923